###begin article-title 0
###xml 76 93 <span type="species:ncbi:11320">influenza A virus</span>
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 1011 1028 <span type="species:ncbi:11320">influenza A virus</span>
Human APOBEC3G is an antiretroviral protein that was described to act via deamination of retroviral cDNA. However, it was suggested that APOBEC proteins might act with antiviral activity by yet other mechanisms and may also possess RNA deamination activity. As a consequence there is an ongoing debate whether APOBEC proteins might also act with antiviral activity on other RNA viruses. Influenza A viruses are single-stranded RNA viruses, capable of inducing a variety of antiviral gene products. In searching for novel antiviral genes against these pathogens, we detected a strong induction of APOBEC3G but not APOBEC3F gene transcription in infected cells. This upregulation appeared to be induced by the accumulation of viral RNA species within the infected cell and occurred in an NF-kappaB dependent, but MAP kinase independent manner. It further turned out that APOBEC expression is part of a general IFNbeta response to infection. However, although strongly induced, APOBEC3G does not negatively affect influenza A virus propagation.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 336 339 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 384 401 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 403 406 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 417 446 <span type="species:ncbi:10804">adeno-associated virus type 2</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 641 646 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 769 772 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 958 963 <span type="species:ncbi:9606">human</span>
###xml 1304 1321 <span type="species:ncbi:11320">influenza A virus</span>
In patients infected with HIV-1, the expression of human apolipoprotein (apo) B mRNA editing enzyme catalytic polypeptide 1-like protein 3G (APOBEC3G) was observed to be elevated [1], although this was not confirmed in cell culture experiments [2,3]. Members of the APOBEC3 family are known to act with anti-retroviral activity against HIV [4,5], but they also inhibit replication of hepatitis B virus (HBV) [6], and adeno-associated virus type 2 [7]. The anti-retroviral activity of human APOBEC3 proteins is probably conferred by cytidine deamination of the newly synthesized first viral cDNA strand. This mechanism is counteracted by the HIV-1 protein virion infectivity factor (Vif) [8-12]. However, human APOBEC3 proteins may not only have anti-retroviral or anti-HBV activity. Two findings have triggered a broader interest in these proteins with regard to a potential antiviral action against RNA viruses. First, besides its DNA deamination activity, human APOBEC3 proteins were reported to also possess RNA deamination activity [13]. Second, DNA deamination activity may not be the only antiviral action of these proteins [13-16] suggesting that APOBEC3s might possess functions that render them effective against other viruses, which do not have any DNA-intermediates during replication such as influenza A virus.
###end p 4
###begin p 5
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 886 887 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1416 1418 1416 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1423 1425 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1586 1587 1586 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1588 1589 1588 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1914 1916 1914 1916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 47 64 <span type="species:ncbi:11320">influenza A virus</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 929 934 <span type="species:ncbi:9606">human</span>
###xml 947 952 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 962 970 <span type="species:ncbi:9606">patients</span>
###xml 1078 1083 <span type="species:ncbi:9606">human</span>
###xml 1243 1260 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1306 1311 <span type="species:ncbi:9606">human</span>
###xml 1454 1459 <span type="species:ncbi:9606">human</span>
###xml 1473 1478 <span type="species:ncbi:9606">human</span>
In global gene expression profiling studies of influenza A virus-infected cells, we observed strongly elevated transcription of human APOBEC3G. This finding was verified by quantitative Real-time PCR (qRT-PCR) [17] with specific primers against APOBEC3G and APOBEC3F (Figure 1A) [18-20] in lung epithelial cells (A549) (Figure 1B) and in primary human endothelial cells (HUVEC) (Figure 1C) infected with the human influenza virus A/Puerto Rico/8/34 H1N1 (PR8). The upregulation of APOBEC3G was also confirmed on protein level as determined in Western blot analysis (Figure 1E). Protein expression steadily increased with time up to 16 hours post infection but dropped again at 24 hours p.i (Figure 1E) most likely due to host cell protein shut-off induced by the virus. Interestingly, such an upregulation of human APOBEC3G transcription was not reported for cells infected with HIV-1 [2,3], although higher expression levels of human APOBEC3G in HIV-1 infected patients is described in the literature [1]. Upregulation of APOBEC3G was also confirmed in cells infected with the human H5N1 influenza virus isolate A/Thailand/(KAN-1)/2004 (H5N1) (data not shown), suggesting that transcriptional induction of APOBEC3G is a general phenomenon in influenza A virus infected cells. Interestingly, the paralogue human APOBEC3F was not found to be upregulated in A549 cells and was only marginally induced in HUVEC (Figure 1B and 1C). This is noteworthy, since human APOBEC3F and human APOBEC3G share more than 90% promoter sequence similarity and appear to be transcriptionally co-regulated [4,5]. However, co-regulated induction of expression was not observed in our experiments. Instead we found that the mRNA copy number of APOBEC3F remains at a constant high level in uninfected and infected A549 cells, while the copy numbers of APOBEC3G are at a low level in uninfected cells and rise upon viral infection (Figure 1D), suggesting distinct transcriptional regulation despite high promoter sequence similarity.
###end p 5
###begin p 6
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Virus-induced human APOBEC3G gene transcription</bold>
###xml 1275 1277 1273 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 1354 1359 <span type="species:ncbi:9606">human</span>
###xml 1373 1378 <span type="species:ncbi:9606">human</span>
###xml 1436 1441 <span type="species:ncbi:9606">human</span>
###xml 1466 1471 <span type="species:ncbi:9606">human</span>
###xml 1738 1743 <span type="species:ncbi:9606">human</span>
###xml 1756 1761 <span type="species:ncbi:9606">human</span>
###xml 1862 1867 <span type="species:ncbi:9606">human</span>
Virus-induced human APOBEC3G gene transcription. (A) Determination of the binding specificity of human APOBEC3F and human APOBEC3G primers in quantitative real time PCR (qRT-PCR). Serial dilutions of the C-terminally HA-tagged plasmids pcDNA_huAPOBEC3F (hA3F) (described by H. Muckenfuss and colleagues) or pcDNA_huAPOBEC3G (generously provided by Nathaniel R. Landau) were analysed using either human APOBEC3F or APOBEC3G specific primer pairs in qRT-PCR. The copy number of each plasmid and the corresponding CT-values (cycle number of the first detectable signal) are given. Low CT-values indicate high amounts of the DNA-sequence of interest. CT-values above 30 are commonly considered as non-specific signals. The qRT-PRC-program is limited to 40 cycles; due to that fact that CT-values >40 indicate undetectable amounts of DNA. (B-E) The influenza virus strain A/Puerto Rico/8/34 H1N1 (PR8) was diluted in PBS containing 0.6% sterile BSA and 1% penicillin/streptomycin and used to infect A549 cells (B and D-E) or HUVEC (C) (MOI = 5) for the time points indicated. At two-hourly intervals post infection, RNA was isolated using the RNeasy mini-kit (Qiagen), and 3 mug of total RNA were transcribed into cDNA using 0.5 mug oligo dT-primer (16 mer) and 200 U Revert Aid H- (Fermentas) according to the manufacture's protocol. mRNA levels of IFNbeta, human APOBEC3F and human APOBEC3G were assessed by qRT-PCR using primer pairs for human APOBEC3F and 3G; or for human IFNbeta as follows: IFNbeta_fwd 5'-GGC CAT GAC CAA CAA GTG TCT CCT CC-3' and IFNbeta_rev 5'-GCG CTC AGT TTC GGA GGT AAC CTG T-3'. Induced transcription of mRNA was calculated as n-fold using GAPDH as reference gene. (D) Determination of the copy numbers per cell of human APOBEC3F or human APOBEC3G. (E) Infected A549 cells were lysed at the time points indicated. Endogenous expression of human APOBEC3G was determined with the hA3G specific antibody ApoC17 (NIH AIDS Research and Reference Reagent Program) in Western blots. An anti-tubulin (B5-1-2, Sigma) blot served as a loading control.
###end p 6
###begin p 7
###xml 389 391 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 392 394 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 541 543 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1156 1158 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1354 1356 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1475 1477 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 59 76 <span type="species:ncbi:11320">influenza A virus</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 489 494 <span type="species:ncbi:9606">human</span>
###xml 769 774 <span type="species:ncbi:9606">human</span>
Given the particular strong induction of human APOBEC3G in influenza A virus-infected cells, we addressed the question which virus-induced intracellular signalling pathways are required for human APOBEC3G mRNA transcription. Influenza virus infection induces a variety of signalling pathways such as the Raf/MEK/ERK kinase cascade, the p38 signalling pathway and the IKK/NFkappaB pathway [21,22]. PMA, an effective inducer of the classical Raf/MEK/ERK cascade, has been reported to induce human APOBEC3G gene expression in H9 cells via PKC [23]. However, in the cell types used in our study, PMA (100-200 ng/ml) was only a weak inducer of APOBEC3G expression, and inhibition of the Raf/MEK/ERK cascade by the MEK inhibitor U0126 (2-10 mug/ml) did not result in reduced human APOBEC3G mRNA levels in virus-infected A549 cells (data not shown). Activation of the p38 signalling cascade by virus infection involves the phosphorylation of p38 by the MAP kinase kinase, MKK6. To block the pathway at this level of the cascade we overexpressed a dominant negative mutant of MKK6 (MKK6Ala) that was previously shown to efficiently suppress the activation of p38 [24]. Successful transduction of the retroviral vector pEGZ-MKK6Ala was monitored by FACS-analysis of GFP (data not shown) that is expressed from a second reading frame of the mRNA of the transgene [24]. Inhibition of the p38 phosphorylation by either stable overexpression of the dominant-negative form of MKK6 (Figure 2A) or application of the p38 inhibitor SB203580 (20 muM) (data not shown) did not affect the induced transcription of APOBEC3G. These findings argue against a prominent role of either, ERK or p38 MAPK cascade in viral APOBEC3G induction.
###end p 7
###begin p 8
###xml 0 47 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#946;-induced transcription of human APOBEC3G</bold>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 494 511 <span type="species:ncbi:11320">influenza A virus</span>
###xml 887 892 <span type="species:ncbi:9606">human</span>
###xml 1071 1076 <span type="species:ncbi:9606">human</span>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
IFNbeta-induced transcription of human APOBEC3G. (A and B) A549 cells stably overexpressing the dominant negative mutants IKK2KD or MKK6Ala. These mutant kinases were cloned in the retroviral pEGZ-vector. In this vector GFP is expressed by an internal ribosomal entry site (IRES) from the same mRNA as the IKK2KD and MKK6Ala transgenes, allowing transgene expression to be monitored by FACS-analysis (data not shown). MKK6Ala and IKK2KD overexpressing cells were infected for 10 hours with the influenza A virus strain PR8 (MOI = 5). Following infection, RNA was isolated with the RNeasy mini kit (Qiagen), reverse transcribed as described above, and cDNA was subjected to qRT-PCR. (C) A549 cells were pre-treated for 30 minutes with the NF-kappaB specific inhibitor BAY 11-7085 (40 muM) before infection with PR8 (MOI = 5) for 10 hours. RNA was subjected to qRT-PCR. The mRNA levels of human APOBEC3G (A and C) or IFNbeta (B) were assessed by qRT-PCR. (D) A549 cells were stimulated with IFNbeta (100 U/ml) (Invitrogen) for the time points indicated. The mRNA levels of human APOBEC3F and human APOBEC3G were determined by means of qRT-PCR. Induction of gene transcription was calculated as n-fold of untreated cells, which was arbitrarily set as 1, as described by Livak and Schmittgen. (E) A549 cells were stimulated as in (D), and cell lysates were subjected to Western blots using the hA3G specific antibody ApoC17 (NIH)
###end p 8
###begin p 9
###xml 272 274 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 652 654 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 655 657 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 777 779 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 848 850 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 999 1001 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
The IKK2/NF-kappaB module is another influenza virus-activated signalling cascade that is known to regulate a variety of genes. This includes IFNbeta transcription, which is controlled by an enhanceosome, composed of the transcription factors IRF3/7, NF-kappaB, and AP-1 [22]. To assess the involvement of IKK2 and NF-kappaB in virus-induced APOBEC3G expression, we used A549 cells that were retrovirally transduced with the vector pEGZ-IKK2KD. This transduction allows for the stable expression of the dominant negative mutant of IkappaB kinase 2 (IKK2), an approach that has been successfully used previously to efficiently blunt NF-kappaB activity [25,26]. Upon infection of these mutant-expressing cells, APOBEC3G mRNA levels were reduced compared to control cells (Figure 2A) to a similar extent that was observed for the IFNbeta gene (Figure 2B). The same pattern of APOBEC3G expression was also observed in infected cells pre-treated with the NF-kappaB inhibitor BAY 11-7085 (40 muM) (Figure 2C). Thus, NF-kappaB activity appeared to be crucial for viral APOBEC3G induction.
###end p 9
###begin p 10
###xml 168 170 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 345 350 <span type="species:ncbi:9606">human</span>
To independently analyse whether NF-kappaB might play a role in APOBEC3G induction, we stimulated cells with TNFalpha (20 ng/ml), a very strong activator of NF-kappaB [27]. However, TNFalpha stimulation did not result in enhanced APOBEC3G gene transcription (data not shown), indicating that NF-kappaB activity alone is not sufficient to induce human APOBEC3G gene transcription.
###end p 10
###begin p 11
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 704 706 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
Influenza virus infection results in type I IFN production (Figure 2B) and subsequent expression of IFN-responsive genes [28-30]. So far, it was not clear from the literature whether human APOBEC3 genes are induced by type I IFNs. While IFN-dependency was reported for the hepatoma cell lines HepG2 and Huh7 [18,31] and for macrophages [32], human APOBEC3 proteins are not inducible in H9 cells by type I and type II IFN [23]. To specifically address this issue for the lung epithelial cell line used in our study, A549 cells were incubated for different time periods with recombinant IFNbeta (100 U/ml) (PBL), and the levels of human APOBEC3G and human APOBEC3F mRNAs were determined by qRT-PCR (Figure 2D).
###end p 11
###begin p 12
###xml 89 91 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 152 154 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 226 228 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 373 375 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 501 506 <span type="species:ncbi:9606">human</span>
IFNbeta stimulation led to a nearly 20-fold induction of the human APOBEC3G mRNA (Figure 2D), which could also be observed at the protein level (Figure 2E); by contrast, the human APOBEC3F mRNA was not affected at all (Figure 2D). Strikingly, this pattern of human APOBEC3G versus human APOBEC3F expression exactly matched the results obtained upon virus infection (Figure 1B). This suggests that IFNbeta, expressed upon virus infection in an NF-kappaB dependent manner, may be an indirect trigger of human APOBEC3G expression, leaving still open the question about the initial viral inducer.
###end p 12
###begin p 13
###xml 238 240 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 241 243 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 673 677 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A&#8211;D</xref>
###xml 881 883 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 888 890 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1005 1007 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1012 1014 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1420 1422 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1427 1429 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1475 1477 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
###xml 1328 1333 <span type="species:ncbi:9606">human</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
IFNbeta transcription in infected cells is known to be mainly induced by single-stranded or partially double-stranded RNA. Such RNA species accumulate during infection within the host cell and serve as a pathogen pattern sensed by cells [33,34]. To examine whether different RNA species serve as inducer of APOBEC3G gene expression, total RNAs isolated from influenza virus infected ("viral RNA") or uninfected cells ("cellular RNA"), or the dsRNA analogue poly (I:C), or short ssRNA bearing a 5'-triphosphate were used as stimuli to elicit a gene response. These RNAs were transfected into A549 cells, and mRNA levels of human APOBEC3G and IFNbeta were determined (Figure 3A-D). While transfection of RNA from uninfected cells led to no significant gene induction, RNA from virally infected cells resulted in upregulation of both, human APOBEC3G and IFNbeta transcription (Figure 3A and 3B). Stimulation using either poly (I:C) or 5'-triphosphate RNA led to even a stronger induction of APOBEC3G (Figure 3C and 3D). In summary, our findings indicate that human APOBEC3G is induced upon viral infection as a part of the antiviral response mediated by type I IFN. This response is triggered by the recognition of different RNA species by distinct receptors such as TLR3, RIG-I and/or MDA-5. Interestingly, we did not observe any human APOBEC3F induction, neither upon viral infection nor with IFNbeta stimulation (Figure 1B and 2D), albeit both promoters carry ISRE elements [35]. Thus, we hypothesized that human APOBEC3G may be selectively induced and may confer a specific antiviral activity in influenza virus infected cells.
###end p 13
###begin p 14
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of human APOBEC3G mRNA by different RNA species</bold>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 940 945 <span type="species:ncbi:9606">human</span>
Induction of human APOBEC3G mRNA by different RNA species. (A and B) A549 cells (1.5 x 106/6 cm dish) were transfected with indicated amounts of total RNA from virally infected ("viral RNA") or uninfected ("cellular RNA") A549 cells. RNA from uninfected or virally infected cells was generated by isolation of total RNA from cells either infected with PR8 (MOI = 5) or from uninfected cells using the Qiagen RNeasy kit according to the manufacturer's instructions. For stimulation, these RNAs were transfected for 10 hours using Lipofectamine 2000 (L2000) (Invitrogen) according to the manufacturer's protocol. (C) A549 cells were transfected with either different amounts of poly (I:C) (Amersham Biosciences) or with 5'-triphosphate RNA (D). 5'-triphosphate RNA was generated by reverse transcription of a short PCR product using the MEGAshortscript kit (Ambion) according to the manufacturer's instructions. mRNA levels of IFNbeta (B) or human APOBEC3G (A, C and D) were determined by qRT-PCR as described. Levels of gene induction were calculated as n-fold of the background of untreated cells, which was arbitrarily set as 1.
###end p 14
###begin p 15
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 1376 1377 1369 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1378 1379 1371 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1453 1454 1446 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1455 1456 1448 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1549 1551 1542 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 724 741 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1060 1077 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1086 1091 <span type="species:ncbi:9606">human</span>
###xml 1186 1191 <span type="species:ncbi:9606">human</span>
###xml 1297 1302 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1346 1351 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1391 1396 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1585 1590 <span type="species:ncbi:9606">human</span>
###xml 1637 1651 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 1689 1694 <span type="species:ncbi:9606">human</span>
###xml 1873 1890 <span type="species:ncbi:11320">influenza A virus</span>
To test this assumption we first transiently over expressed HA-tagged human APOBEC3G (Figure 4B) and assessed the efficiency of viral propagation in these cells. Surprisingly, in the presence of human APOBEC3G, progeny virus titres were slightly elevated compared to the vector control (Figure 4A, white bars). This correlated with a slightly higher expression level of the viral polymerase subunit PB1 (Figure 4B). To circumvent potential transient transfection artefacts and to enhance the number of transgene-expressing cells, we generated cell lines, stably expressing human APOBEC3G (Figure 4C and 4D). After selection of stably APOBEC3G expressing cells by antibiotic treatment, the cells were infected with different influenza A virus strains at various multiplicities of infection (MOI) (Figure 4A, grey and black bars). In contrast to the transient situation, viral propagation was not affected in these stably transfected cells, although the transgene was expressed well in MDCK cells (Figure 4C) as well as in A549 cells (Figure 4D). Thus, although influenza A virus induces human APOBEC3G transcription in an NF-kappaB and IFNbeta dependent manner, the forced expression of human APOBEC3G did not result in any antiviral effect on this virus. This is different from the situation with HIV-1. APOBEC3G shows antiviral activity against HIV-1 and other retroviruses [8,2]. However, HIV-1 does not induce APOBEC3G transcription in cell culture [2,3]. In support of a specific rather than broad antiviral activity of APOBEC3G, Kremer et al. [36] had reported that overexpressed human APOBEC3G also has no antiviral effect against vaccinia virus (VACV). In summary, we conclude that human APOBEC3G is induced by influenza A viral RNA, via an NF-kappaB dependent mechanism as part of the antiviral IFN response program but does not exhibit an antiviral effect against influenza A virus.
###end p 15
###begin p 16
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Influence of the human APOBEC3G protein on viral replication</bold>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 209 212 <span type="species:ncbi:11313?0.3020408163265306|species:ncbi:10261?0.2571428571428571|species:ncbi:10786?0.17142857142857143|species:ncbi:10785?0.07755102040816327">FPV</span>
###xml 235 238 <span type="species:ncbi:11313?0.3020408163265306|species:ncbi:10261?0.2571428571428571|species:ncbi:10786?0.17142857142857143|species:ncbi:10785?0.07755102040816327">FPV</span>
###xml 1031 1034 <span type="species:ncbi:11313?0.3020408163265306|species:ncbi:10261?0.2571428571428571|species:ncbi:10786?0.17142857142857143|species:ncbi:10785?0.07755102040816327">FPV</span>
###xml 1153 1158 <span type="species:ncbi:9606">human</span>
Influence of the human APOBEC3G protein on viral replication. (A) Transiently (white bars) or stably human APOBEC3G transfected (light and dark grey bars) MDCK cells were infected with avian influenza virus A/FPV/Bratislava/79 (H7N7) (FPV) (MOI = 0.05) for 9 hours or A/Puerto Rico/8/34 H1N1 (PR8) (MOI = 0.1) virus for 16 hours. Both virus strains were originally taken from the collection of the Institute of Virology, University of Giessen, Germany. Stably transfected A549 cells (black bars) were infected with PR8 for 16 hours (MOI = 0.01). Supernatants were taken, and virus titres were determined by means of plaque assay. (B and C) MDCK cells or (D) A549 cells were transfected with 3 mug DNA/6 well dish pcDNA-APOBEC3G or pcDNA3.1 empty vector using L2000 (Invitrogen) according to manufacturer's instructions. To generate a bulk amount of stable expressing cells, MDCK cells (C) or A549 cells (D) were treated with G418 300 mug/ml for selection of APOBEC3G expression for four weeks. Thereafter, cells were infected with FPV at MOI = 0.05 (B) or at MOI = 0.1 for 9 hours (C) or with PR8 at MOI = 0.001 for 16 hors (D). Expression of HA-tagged human-APOBEC3G was detected by anti-HA 3F10 (Roche) antibody. To control equivalent protein loading, ERK2 or JNK were detected by anti-ERK2 (Santa Cruz) or anti-JNK antibody (Santa Cruz). Viral replication was monitored by detection of the viral polymerase protein using an anti-PB1 antibody (Santa Cruz).
###end p 16
###begin title 17
Competing interests
###end title 17
###begin p 18
The authors declare that they have no competing interests.
###end p 18
###begin title 19
Authors' contributions
###end title 19
###begin p 20
EKP, MS, CE and HH have performed experimental work, contributed data and gave conceptual input in the study design. EF and CM have provided important material and have been involved in drafting the manuscript and revising it critically for important intellectual content. SL has designed and has guided the study, interpreted the data and wrote the manuscript.
###end p 20
###begin title 21
Acknowledgements
###end title 21
###begin p 22
###xml 390 405 390 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FluResearchNet </italic>
The following reagent was obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: anti-ApoC17 from Dr. Klaus Strebel. This work was supported by several grants from the Deutsche Forschungsgemeinschaft (DFG) (Lu477-11/2, SFB293 A17, Graduate School GRK1409), the Interdisciplinary Clinical Research Centre (IZKF) of the University of Munster, the FluResearchNet funded by the German Ministry of Education and Research (BMBF), and the EC funded STREP EUROFLU.
###end p 22
###begin article-title 23
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F
###end article-title 23
###begin article-title 24
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
###end article-title 24
###begin article-title 25
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
###end article-title 25
###begin article-title 26
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
###end article-title 26
###begin article-title 27
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
###end article-title 27
###begin article-title 28
###xml 14 31 <span type="species:ncbi:10407">hepatitis B virus</span>
Inhibition of hepatitis B virus replication by APOBEC3G
###end article-title 28
###begin article-title 29
###xml 34 56 <span type="species:ncbi:272636">adeno-associated virus</span>
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
###end article-title 29
###begin article-title 30
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 30
###begin article-title 31
DNA deamination mediates innate immunity to retroviral infection
###end article-title 31
###begin article-title 32
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
###end article-title 32
###begin article-title 33
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vif, APOBEC, and intrinsic immunity
###end article-title 33
###begin article-title 34
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)
###end article-title 34
###begin article-title 35
APOBEC-mediated editing of viral RNA
###end article-title 35
###begin article-title 36
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
###end article-title 36
###begin article-title 37
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity
###end article-title 37
###begin article-title 38
###xml 56 91 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count
###end article-title 38
###begin article-title 39
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method
###end article-title 39
###begin article-title 40
###xml 74 79 <span type="species:ncbi:9606">human</span>
Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes
###end article-title 40
###begin article-title 41
###xml 25 30 <span type="species:ncbi:9606">human</span>
APOBEC3 proteins inhibit human LINE-1 retrotransposition
###end article-title 41
###begin article-title 42
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
###end article-title 42
###begin article-title 43
Exploited defense: how influenza viruses take advantage of antiviral signaling responses
###end article-title 43
###begin article-title 44
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells
###end article-title 44
###begin article-title 45
###xml 79 107 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus
###end article-title 45
###begin article-title 46
The stress inducer arsenite activates mitogen-activated protein kinase extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway
###end article-title 46
###begin article-title 47
NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation
###end article-title 47
###begin article-title 48
###xml 123 128 <span type="species:ncbi:9606">human</span>
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells
###end article-title 48
###begin article-title 49
NF-kappa B activation by tumor necrosis factor and interleukin-1
###end article-title 49
###begin article-title 50
A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling
###end article-title 50
###begin article-title 51
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events
###end article-title 51
###begin article-title 52
###xml 38 55 <span type="species:ncbi:11320">influenza A virus</span>
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza
###end article-title 52
###begin article-title 53
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 98 115 <span type="species:ncbi:10407">hepatitis B virus</span>
Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication
###end article-title 53
###begin article-title 54
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity
###end article-title 54
###begin article-title 55
5'-Triphosphate RNA is the ligand for RIG-I
###end article-title 55
###begin article-title 56
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates
###end article-title 56
###begin article-title 57
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells
###end article-title 57
###begin article-title 58
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus replication is not affected by APOBEC3 family members
###end article-title 58

